Literature DB >> 2961804

L3T4+ cytotoxic T lymphocytes specific for class I H-2 antigens are activated in primary mixed lymphocyte reactions.

S Macphail1, O Stutman.   

Abstract

Thy-1+, L3T4+, Ly-2- cytotoxic lymphocytes (CTL) are generated in a primary anti-H-2d mixed lymphocyte reaction, by using responders depleted of Ly-2+ cells. In addition to expressing the L3T4 marker, as detected by anti-L3T4 antibody and complement-mediated elimination, the L3T4+ CTL are inhibited by L3T4 antibody. The observation of these L3T4+ CTL in cells recovered from primary mixed lymphocyte reactions confirms the previous reports. However it is demonstrated for the first time that a subpopulation of these are class I-specific by their specific inhibition with an antiserum to class I antigens. The class I specificity of the CTL was further shown by their ability to kill class II antigen negative P815 tumor cells. The lysis of this target cell by L3T4+ CTL was also specifically blocked by the class I antiserum. The data is consistent with the presence also of a class II-specific population of L3T4+ cytotoxic cells. The fact that a level of L3T4+ cell-mediated cytotoxic activity comparable to Ly-2+ cytolytic activity is generated in a primary mixed lymphocyte response, even though the precursor frequency of L3T4+ killer cells is 10 times lower than for Ly-2+ killers, is suggestive of their physiologic significance. It was also shown that the activation of these cells is not dependent on the presence of xenogeneic serum components or exogenous helper or mitogenic factors in the culture medium. The findings provide further evidence against both the phenotype-function and phenotype-major histocompatibility complex antigen specificity models of T cell diversity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2961804

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Anti-L3T4 antibody inhibits the lysis of H-2 class II antigen-negative target cells by L3T4+ cytotoxic T lymphocytes.

Authors:  S Macphail; O Stutman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

2.  The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice.

Authors:  H Auchincloss; R Lee; S Shea; J S Markowitz; M J Grusby; L H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

3.  Trojan horse lymphocytes: a vesicular stomatitis virus-specific T-cell clone lyses target cells by carrying virus.

Authors:  R C Hom; G Soman; R Finberg
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

4.  Recognition of Epstein-Barr virus (EBV)-infected cells by T cell colonies from a human chimera: restriction by allogeneic determinants.

Authors:  H Plotnicky; J L Touraine
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

5.  Expression of CD4 in transgenic mice alters the specificity of CD8 cells for allogeneic major histocompatibility complex.

Authors:  E Robey; F Ramsdell; J Elliott; D Raulet; D Kioussis; R Axel; B J Fowlkes
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

6.  Lymphokine mRNA profile and functional analysis of a human CD4+ clone with unique antitumor specificity isolated from renal cell carcinoma ascitic fluid.

Authors:  A Belldegrun; A Kasid; M Uppenkamp; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

7.  Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor.

Authors:  J Kirberg; A Baron; S Jakob; A Rolink; K Karjalainen; H von Boehmer
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

8.  Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules.

Authors:  J Kirberg; A Berns; H von Boehmer
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

9.  Differential involvement of CD4+ cells in mediating skin graft rejection against different amounts of transgenic H-2K(b) antigen.

Authors:  M Kawai; Y Obata; N Hamasima; T Takahashi; A Uenaka; M Monden; T Mori; H Shiku; E Nakayama
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.